<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.0" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">jkra</journal-id>
<journal-title-group>
<journal-title>The Journal of the Korean Rheumatism Association</journal-title>
<abbrev-journal-title>J Korean Rheum Assoc</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1226-8070</issn>
<issn pub-type="epub">2233-4718</issn>
<publisher>
<publisher-name>The Korean Rheumatism Association</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.4078/jkra.2010.17.4.422</article-id>
<article-id pub-id-type="publisher-id">jkra-17-422</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Case of Bullous Pemphigoid Arising after Infliximab Therapy in a Patient with Rheumatoid Arthritis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Park</surname><given-names>Seong Oh</given-names></name>
<xref ref-type="aff" rid="aff1-jkra-17-422"/>
</contrib>
<contrib contrib-type="author">
<name name-style="western" xml:lang="en"><surname>Lee</surname><given-names>Ji Hyun</given-names></name>
<xref ref-type="aff" rid="aff1-jkra-17-422"/>
</contrib>
<aff id="aff1-jkra-17-422">Department of Rheumatology, Maryknoll Hospital, Busan, Korea</aff>
</contrib-group>
<pub-date pub-type="ppub"><month>12</month><year>2010</year></pub-date>
<pub-date pub-type="epub"><day>23</day><month>12</month><year>2010</year></pub-date>
<volume>17</volume>
<issue>4</issue>
<fpage>422</fpage>
<lpage>425</lpage>
<history>
<date date-type="received"><day>10</day><month>06</month><year>2010</year></date>
<date date-type="revised"><day>11</day><month>08</month><year>2010</year></date>
<date date-type="accepted"><day>12</day><month>08</month><year>2010</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2010 The Korean Rheumatism Association</copyright-statement>
<copyright-year>2010</copyright-year>
<license><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license>
</permissions>
<abstract xml:lang="en">
<title>Abstract</title>
<p>Bullous pemphigoid is an autoimmune, subepidermal blistering disease commonly seen in the elderly. It is known as autoimmune bullous dermatoses with an estimated prevalence of 1 in 40,000 and shows no gender or racial predilection. It has an autoimmune nature with immunoglobulin (Ig) G and/or C3 complement targeting hemidesmosomal antigens located in the epidermal basement membrane zone. Drug-induced pemphigoid, although rare, can occur in patients taking penicillamine, furosemide, captopril, penicillin, or sulfasalazine, but infliximab-induced pemphigoid has not been reported. We experienced a case of infliximab-induced pemphigoid in 54-year-old woman with a 17-year history of rheumatoid arthritis.</p>
</abstract>
<kwd-group xml:lang="en">
<kwd>Infliximab</kwd><kwd>Bullous pemphigoid</kwd><kwd>Rheumatoid arthritis</kwd>
</kwd-group>
</article-meta>
</front>
<back>
<ref-list xml:lang="en"><title>REFERENCES</title>
<ref id="b1"><element-citation publication-type="book"><label>1)</label><source>Cleveland Clinic: Current Clinical Medicine 2009</source> <edition>1st ed.</edition> <comment>Chapter 44</comment> <publisher-name>Philadelphia, PA, Saunders</publisher-name> <year>2009</year></element-citation></ref>
<ref id="b2"><element-citation publication-type="book"><label>2)</label><person-group person-group-type="author"><name><surname>Ferri</surname> <given-names>FF</given-names></name></person-group> <source>Ferri&#x0027;s Clinical Advisor 2010</source> <edition>1st ed.</edition> <fpage>240</fpage> <publisher-name>Philadelphia, PA, MOSBY</publisher-name> <year>2010</year></element-citation></ref>
<ref id="b3"><element-citation publication-type="journal"><label>3)</label><person-group person-group-type="author"><name><surname>Duong</surname> <given-names>TA</given-names></name> <name><surname>Buffard</surname> <given-names>V</given-names></name> <name><surname>AndreA</surname> <given-names>C</given-names></name> <name><surname>Ortonne</surname> <given-names>N</given-names></name> <name><surname>Revuz</surname> <given-names>J</given-names></name> <name><surname>Bagot</surname> <given-names>M</given-names></name> <etal/></person-group> <article-title>Efalizumab-induced bullous pemphigoid</article-title> <source>J Am Acad Dermatol</source> <year>2010</year> <volume>62</volume> <fpage>161</fpage><lpage>2</lpage></element-citation></ref>
<ref id="b4"><element-citation publication-type="journal"><label>4)</label><person-group person-group-type="author"><name><surname>Rongioletti</surname> <given-names>F</given-names></name> <name><surname>Parodi</surname> <given-names>A</given-names></name> <name><surname>Rebora</surname> <given-names>A</given-names></name></person-group> <article-title>Dyshidrosiform pemphigoid: report of an additional case</article-title> <source>Dermatologica</source> <year>1985</year> <volume>170</volume> <fpage>84</fpage></element-citation></ref>
<ref id="b5"><element-citation publication-type="journal"><label>5)</label><person-group person-group-type="author"><name><surname>Levine</surname> <given-names>N</given-names></name> <name><surname>Freilich</surname> <given-names>A</given-names></name> <name><surname>Barland</surname> <given-names>P</given-names></name></person-group> <article-title>Localized pemphigoid simulating dyshidrosiform dermatitis</article-title> <source>Arch Dermatol</source> <year>1979</year> <volume>115</volume> <fpage>320</fpage><lpage>1</lpage></element-citation></ref>
<ref id="b6"><element-citation publication-type="journal"><label>6)</label><person-group person-group-type="author"><name><surname>Tamai</surname> <given-names>K</given-names></name> <name><surname>Li</surname> <given-names>K</given-names></name> <name><surname>Uitto</surname> <given-names>K</given-names></name></person-group> <article-title>Idendification of a DNA-binding protein (keratinocyte transcriptional protein-1) recognizing a keratinocyte-specific regulatory element in the 230 kDa bullous pemphigoid antigen gene</article-title> <source>J Biol Chem</source> <year>1994</year> <volume>269</volume> <fpage>493</fpage><lpage>502</lpage></element-citation></ref>
<ref id="b7"><element-citation publication-type="journal"><label>7)</label><person-group person-group-type="author"><name><surname>Pfau</surname> <given-names>A</given-names></name> <name><surname>Hohenleutner</surname> <given-names>U</given-names></name> <name><surname>Hohenleutner</surname> <given-names>S</given-names></name> <name><surname>Eckert</surname> <given-names>F</given-names></name> <name><surname>Landthaler</surname> <given-names>M</given-names></name></person-group> <article-title>UVA-provoked localized bullous pemphigoid</article-title> <source>Acta Derm Venereol</source> <year>1994</year> <volume>74</volume> <fpage>314</fpage><lpage>6</lpage></element-citation></ref>
<ref id="b8"><element-citation publication-type="journal"><label>8)</label><person-group person-group-type="author"><name><surname>Bordignon</surname> <given-names>M</given-names></name> <name><surname>Belloni-Fortina</surname> <given-names>A</given-names></name> <name><surname>Pigozzi</surname> <given-names>B</given-names></name> <name><surname>Tarantello</surname> <given-names>M</given-names></name> <name><surname>Alaibac</surname> <given-names>M</given-names></name></person-group> <article-title>Bullous Pemphigoid during Long-Term TNF-a Blocker Therapy</article-title> <source>Dermatology</source> <year>2009</year> <volume>219</volume> <fpage>357</fpage><lpage>8</lpage></element-citation></ref>
<ref id="b9"><element-citation publication-type="journal"><label>9)</label><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>YT</given-names></name> <name><surname>Liu</surname> <given-names>HN</given-names></name> <name><surname>Wong</surname> <given-names>CK</given-names></name></person-group> <article-title>Bullous pemphigoid: a report of 86 cases from Taiwan</article-title> <source>Clin Exp Dermatol</source> <year>1996</year> <volume>21</volume> <fpage>20</fpage><lpage>2</lpage></element-citation></ref>
<ref id="b10"><element-citation publication-type="journal"><label>10)</label><person-group person-group-type="author"><name><surname>Heffernan</surname> <given-names>MP</given-names></name> <name><surname>Bentley</surname> <given-names>DD</given-names></name></person-group> <article-title>Successful treatment of mucous membrane pemphigoid with infliximab</article-title> <source>Arch Dermatol</source> <year>2006</year> <volume>142</volume> <fpage>1268</fpage><lpage>70</lpage></element-citation></ref></ref-list>
<sec sec-type="display-objects">
<title>Figures</title>
<fig id="f1-jkra-17-422" position="anchor">
<label>Fig. 1.</label>
<caption><p>Multiple vesicles and erosion on groin.</p></caption>
<graphic xlink:href="jkra-17-422f1.tif"/>
</fig>
<fig id="f2-jkra-17-422" position="anchor">
<label>Fig. 2.</label>
<caption><p>Vesicle on third finger, left.</p></caption>
<graphic xlink:href="jkra-17-422f2.tif"/>
</fig>
<fig id="f3-jkra-17-422" position="anchor">
<label>Fig. 3.</label>
<caption><p>Subepidermal bullae was found with inflammatory infiltrates on the dermis (hematoxylin and eosin, &#x00D7;100).</p></caption>
<graphic xlink:href="jkra-17-422f3.tif"/>
</fig>
<fig id="f4-jkra-17-422" position="anchor">
<label>Fig. 4.</label>
<caption><p>Immunofluorescent stain of patient&#x0027;s serum shows linear pattern of IgG deposition on the epidermal basement membrane of normal skin.</p></caption>
<graphic xlink:href="jkra-17-422f4.tif"/>
</fig>
</sec>
</back>
</article>
